Haemonetics (HAE) Financial Ratios: P/E, ROE & More

Haemonetics (HAE) Financial Ratios

For fiscal 2026 (fiscal year ended Mar 28, 2026), Haemonetics had a P/E ratio of 25.81 (up from 18.93), return on equity of 12.0% (down from 18.8%), debt-to-equity of 1.60 (up from 1.56) and a current ratio of 2.95 (up from 1.62). A current ratio of 2.95 means current assets exceed current liabilities.

Haemonetics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Mar 2026	Mar 2025	Mar 2024	Apr 2023	Apr 2022	Apr 2021
Valuation Ratios
P/E Ratio	25.81	18.93	36.87	36.17	75.24	72.28
Forward P/E	10.46	13.21	20.49	25.45	23.82	33.88
P/S Ratio	1.88	2.33	3.31	3.57	3.29	6.55
P/B Ratio	3.15	3.87	4.51	5.10	4.36	7.79
Price/Tangible Book	-	-	-	54.93	-	7.85
Price/FCF	9.64	22.29	30.18	51.08	43.08	79.42
Price/OCF	8.56	17.47	23.85	15.29	18.95	52.38
PEG Ratio	0.96	1.00	1.39	2.42	1.36	2.46
Enterprise Value Ratios
EV/Revenue	2.53	3.05	3.83	4.04	3.83	7.14
EV/EBITDA	9.44	11.64	17.04	18.72	19.87	35.71
EV/EBIT	13.41	16.78	24.38	28.21	36.22	69.25
EV/FCF	12.95	29.10	34.89	57.71	50.28	86.60
Profitability & Returns
Return on Equity (ROE)	12.03%	18.83%	13.22%	14.73%	5.86%	12.05%
Return on Assets (ROA)	6.49%	6.65%	6.22%	5.51%	3.57%	6.34%
Return on Invested Capital (ROIC)	10.56%	11.33%	10.55%	10.14%	5.40%	7.64%
Return on Capital Employed (ROCE)	11.90%	13.20%	10.80%	9.90%	7.40%	7.02%
Leverage & Solvency Ratios
Debt/Equity	1.60	1.56	0.91	1.02	1.12	0.97
Debt/EBITDA	3.47	3.49	2.87	3.28	4.14	4.07
Debt/FCF	4.89	9.01	6.08	10.16	11.07	9.86
Liquidity Ratios
Current Ratio	2.95	1.62	2.56	3.06	1.71	2.74
Quick Ratio	1.64	0.88	1.29	1.84	0.95	1.26
Efficiency Ratios
Asset Turnover	0.55	0.59	0.63	0.62	0.54	0.56
Inventory Turnover	1.61	1.71	2.08	1.98	1.50	1.59
Yield & Distribution Ratios
Earnings Yield	3.88%	5.28%	2.71%	2.76%	1.33%	1.38%
FCF Yield	10.37%	4.49%	3.31%	1.96%	2.32%	1.26%
Buyback Yield	6.66%	1.30%	0.05%	-0.13%	-0.12%	1.01%
Total Return	-	-	-	-	-	1.01%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 27, 2026. Data sources and methodology

Frequently Asked Questions About Haemonetics Financial Ratios

What is Haemonetics's P/E ratio?

Haemonetics's P/E ratio was 25.81 for fiscal 2026 (period ended Mar 28, 2026). It was 18.93 a year earlier.

What is Haemonetics's return on equity?

Haemonetics's return on equity (ROE) was 12.0% for fiscal 2026 (period ended Mar 28, 2026). It was 18.8% a year earlier.

What is Haemonetics's debt-to-equity ratio?

Haemonetics's debt-to-equity ratio was 1.60 for fiscal 2026 (period ended Mar 28, 2026). It was 1.56 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition